HopeStage
Back to all studies
RecruitingNCT07039370

Biological markers of TMS response in treatment-resistant depression

About this titleRead the official source — NCT07039370
Device studyAges 18–65Türkiye
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Ankara and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 15, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
55
Sponsor
Gulhane Training and Research Hospital
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
Device
Locations
Türkiye
Age range
From 18 Years to 65 Years
Official registry ID
NCT07039370
Official title
Show the full official title

The Relationship Between Plasma Metabolomics and Proteomics Profiling and Response to Transcranial Magnetic Stimulation Therapy in Treatment-Resistant Depression

Recruitment & locations

Currently recruiting

Ankara, Türkiye · Türkiye

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Gulhane Training and Research Hospital, a hospital or academic medical center.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies